DEFENDO
Showing 1 - 2 of 2
DEFENDO Long Term Follow-up Study in Stage 1 NK Patients
Not yet recruiting
- Neurotrophic Keratitis
- Cenegemin in the DEFENDO Study
-
San Diego, California
- +2 more
Dec 12, 2022